Revenue segments as reported by the company.

Subscription services

Professional services and other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

General and admin

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Veeva Systems

Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007, and is headquartered in Pleasanton, CA.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Veeva Systems reports robust Q1 earnings, eyes growth opportunities

Veeva Systems delivered strong financial performance in Q1 2023, driven by robust execution and competitive wins. The company's focus on innovation, AI capabilities, and the transition to Vault CRM presents significant growth opportunities. However, challenges in the funding environment and customer migrations pose potential hurdles.

Veeva exceeds Q2 expectations, anticipates growth in clinical and data business

Veeva's Q2 performance exceeded expectations, leading to an increase in full-year guidance. The company's strengths lie in strong clinical activity, customer wins, and a focus on product excellence. However, challenges include migration costs, competitive landscape considerations, and marketing spend scrutiny. Veeva sees opportunities in M&A, minimal impact from R&D trends, and expansion of Veeva Link.

Veeva Systems surpasses Q3 expectations, eyes clinical data opportunity

Veeva Systems delivered a strong Q3 performance, with solid revenue and operating income. While facing challenges in billings and macroeconomic uncertainties, the company remains confident in its revenue target for fiscal year '25. The commitment from major enterprises and the potential in clinical data present significant opportunities for future growth.

Veeva Systems reports strong Q4 performance and forecasts $2.8B revenue

Veeva Systems showcases strong performance and strategic planning with revenue growth expectations of at least 15% in fiscal '24 and '25.
Positive feedback on product transitions and development, along with specialized sales teams, highlights market acceptance and innovation.
Challenges include short-term revenue impacts from timing-related issues and macro environment effects on customer spending.
Opportunities lie in revenue growth forecasts, product innovation, and market differentiation through new offerings and strategic deals.

Veeva Systems reports robust Q1 revenue growth and strategic focus

Veeva Systems' Q1 performance reflects strong revenue growth and a focus on customer-centric innovation. The company faces challenges in project scrutiny and competition but has opportunities in new product monetization and segment expansion.

Veeva Systems excels in Q2, eyes disciplined growth and innovation

Veeva Systems showcased robust financial performance, exceeding revenue and operating income targets, with a strong focus on customer success and product excellence.
While facing challenges such as migration costs and regulatory impacts, Veeva is well-positioned to leverage opportunities in disciplined M&A and product innovation.
The company's strategic growth initiatives, including Veeva Link expansion and CRM platform enhancements, aim to drive continued success and value for customers.

Veeva Systems posts solid Q3 results, eyes growth opportunities

Veeva Systems delivered a strong Q3 performance with solid revenue and operating income, showcasing financial stability and growth potential.
Despite challenges like trimmed billings and deal delays, Veeva remains confident in its fiscal year '25 revenue target, emphasizing strategic focus and operational efficiency.
The company's strengths in innovative products, strong partnerships, and global support ecosystem position it well for future growth and market leadership.
Opportunities in customer migration, AI integration, and market demand present avenues for Veeva to drive revenue growth and enhance its competitive positioning in the industry.

Veeva Systems excels in Q4 earnings, poised for strategic growth

Veeva Systems delivered strong financial performance in Q4 2024, showcasing revenue growth, operating income efficiency, and strategic product advancements.
The company's focus on innovation, customer success, and disciplined financial guidance positions it well for future growth and market leadership.
While facing challenges related to market uncertainties and operational considerations, Veeva remains resilient and poised to capitalize on opportunities for expansion and differentiation.
Overall, Veeva's Q4 earnings call highlights a balanced approach to growth, operational excellence, and strategic decision-making in a dynamic business environment.

Veeva Systems beats Q1 guidance, lowers full-year outlook amid challenges

Veeva Systems had a strong start to the year, exceeding Q1 guidance but lowering full-year revenue outlook due to macro challenges.
The company's performance in margin, client adoption, and innovation remains robust, with a focus on stability and predictability amidst industry challenges.
Challenges include AI disruption impacting plans, lower revenue guidance, and delays in funding benefits due to global conflicts and interest rate sensitivity.
Opportunities lie in new client bases, EDC deals progress, and the potential growth of Vault Basics and Link products in the market.

Veeva Systems excels in Q2, eyes strategic growth opportunities

Veeva Systems delivered a strong Q2 performance with revenue of $676 million and non-GAAP operating income of $280 million, driven by product expansions and customer wins.
The company's strengths lie in its comprehensive clinical suite, customer comfort with CRM solutions, and the importance of professional services for customer success.
Challenges include short-term billing growth constraints and the need for continuous product excellence, while opportunities exist in data architecture enhancement and upcoming Investor Day insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Veeva Systems: Growth Curve Is Tapering

Veeva Systems: Salesforce's Little Brother In The Biotech Industry

Intuitive Surgical

Medtronic

These industry leaders will emerge from the coronavirus pandemic stronger than ever.

3 Best Healthcare Stocks to Buy for the Next Decade

Shares of the life sciences industry-focused cloud solutions provider bucked the coronavirus-driven market sell-off last month.

Why Veeva Systems Stock Gained 10% in March While the Market Plunged

ANSYS

DocuSign

RingCentral

Atlassian

Software growth stocks feasted on cloud computing, digital transformation and AI projects. But the coronavirus emergency will slow June quarter revenue growth for software stocks.

Software Growth Stocks To Buy: Coronavirus Impact Coming In June Quarter

HUYA Inc - ADR

Twilio

Huya and two other growth stocks are weathering the coronavirus crisis.

3 Growth Stocks  for In-the-Know Investors

CyberArk Software

Micron Technology

Seagate Technology Holdings PLC

Chinese video streaming platforms, cloud services, cybersecurity firms, and data center suppliers should all survive the coming storm.

4 Tech Industries Positioned to Weather the Coronavirus Crisis

Veeva (VEEV) reported earnings 30 days ago. What's next for the stock?

Veeva (VEEV) Up 6.5% Since Last Earnings Report: Can It Continue?

The customer relationship management (CRM) product developed by Veeva Systems (NYSE: VEEV) is seeing ten times more usage during the novel coronavirus (COVID-19) outbreak, the company's CEO Peter Gassner told CNBC.

Veeva Systems' CRM Product Is Seeing Ten Times More Usage During Coronavirus Pandemic

Veeva Systems CEO Peter Gassner said its customer relationship management platform has been made free to help in the research and development of medical solutions for coronavirus.

Veeva Systems sees product usage increase tenfold as biotech companies race to find COVID-19 cure

Cerner

Teladoc

As Covid-19 floods hospitals in certain affected areas, doctor’s offices around the world are seeing their number of appointments spike as people come in to be tested for the virus.

3 Digital Health Care Stocks to Consider as Doctors Move Online

Amazon

JD.com

Rite Aid

J. M. Smucker

ShotSpotter

Stamps.com

These stocks have defied the 2020 selloff. This means they may be stocks to buy for investors betting a broad market bottom is on the way.

7 Stocks to Buy That Have Survived the Recent Carnage

Dropbox

With the coronavirus changing the game, cloud computing is becoming even more important. These three cloud stocks could be big winners from the shift in our habits.

3 Cloud Computing Stocks That Are Winning From the Coronavirus

Stocks To Buy When The Selling Stops, Part I - Veeva Systems

Another year in the books, another rosy forecast.

Veeva Systems Remains a Top Healthcare Technology Stock Pick

The cloud-based software company fired on all cylinders in the fourth quarter.

How Veeva Systems Vaulted Above Wall Street Estimates in Q4

Veeva Systems' (VEEV) CEO Peter Gassner on Q4 2020 Results - Earnings Call Transcript

Veeva (VEEV) delivered earnings and revenue surprises of 3.85% and 4.49%, respectively, for the quarter ended January 2020. Do the numbers hold clues to what lies ahead for the stock?

Veeva Systems (VEEV) Tops Q4 Earnings and Revenue Estimates

Veeva Systems (VEEV) earnings for the cloud-computing company's fiscal fourth quarter of 2019 have VEEV stock taking off after-hours Tuesday.
The post Veeva Systems Earnings: VEEV Stock Soars 5% on Strong Q4 Beat appeared first on InvestorPlace.

Veeva Systems Earnings: VEEV Stock Soars 5% on Strong Q4 Beat

Veeva Systems Inc. VEEV, -1.77% shares rallied in the extended session Tuesday after the cloud-based software company's results and outlook topped Wall Street estimates.

Veeva Systems stock rallies as earnings, outlook beats Street

Veeva reported adjusted earnings of 42 cents a share and $311.5 million in sales, beating estimates Tuesday. In response, VEEV stock popped.

Highly Rated Medical Stock Pops After Handily Beating Quarterly Estimates

AbbVie

Amgen

Coronavirus has many investors looking for a health stock bump, but these names are great for the long haul.

3 Top Healthcare  Stocks to Buy Right Now

Successfully growing this software-as-a-service company requires a critical element.

Where Will Veeva Systems Be in 5 Years?

Veeva: A Compelling Buy In The Niche Healthcare Cloud Sector

Salesforce

Two well-established and fast-growing software-as-a-service companies. Which deserves your hard-earned investing cash?

News for Veeva Systems Stock (VEEV)